VELTIS
Live / Allowed — Publication / registration review complete (as of 28 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99250298
- Mark type
- Stylized text
- Filed
- 24 Jun 2025
- Published for opposition
- 15 Sept 2026
- Attorney of record
- Russell C. Pangborn
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; Reagents for medical pharmaceutical use, namely, for the stabilization, solubilization and preservation of therapeutic preparations and vaccines; Reagents for medical use; Diagnostic reagents for medical use; Proteins for pharmaceutical and medical purposes, namely, human and synthetic proteins, therapeutic proteins, recombinant albumin, human serum albumin and recombinant human albumin for use as cellular absorption, enzyme stabilizers and anti-coagulant agents for medical laboratory use; Albumin for pharmaceutical and medical purposes, namely, recombinant human albumin sold as an integral component of a vaccine and pharmaceuticals for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; Recombinant albumin for use as a reagent for medical purposes; Diagnostic contrast agents for medical imaging
Owner
- Sartorius Albumedix Limited, Nottingham, GB
Prior registrations
Prosecution history
- 09 Sept 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Aug 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Aug 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Aug 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Aug 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 06 Jun 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 06 Jun 2026 — FINAL REFUSAL E-MAILED
- 06 Jun 2026 — FINAL REFUSAL WRITTEN
- 06 May 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 May 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 May 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Feb 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 11 Feb 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 21 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Nov 2025 — NON-FINAL ACTION E-MAILED